QTREX Quantum Ltd designs and manufactures cryogenic interconnect systems used in quantum computing systems... Show more
QTREX Quantum Ltd. has repositioned itself around a narrowly defined but strategically valuable layer of the quantum computing stack: the high-density, thermally optimized wiring that connects room-temperature control electronics to the millikelvin environment inside a dilution refrigerator. As superconducting systems scale from hundreds to thousands of qubits, conventional hand-assembled cabling becomes a constraint on thermal load, mechanical congestion, and signal integrity. QTEX's AME approach — printing conductors, radio-frequency dielectric, shielding, and thermal management into a single monolithic interconnect structure — is designed to address that constraint directly.
The competitive landscape remains challenging. QTEX faces large global interconnect conglomerates expanding into cryogenic technologies as well as specialized engineering firms. Its differentiation rests on an integrated manufacturing platform backed by years of prior R&D, with a stated target of roughly 20 fully shielded conductors per square centimeter. The company's U.S. subsidiary, formed in July 2026, is aimed at accelerating federal government contracting, which is likely to be a meaningful demand channel given rising public investment in quantum infrastructure.
The most consequential near-term catalyst is whether the company's advanced discussions with a top-five global quantum computing player convert into a definitive commercial agreement. A signed deal could embed QTEX as a foundational cryogenic interconnect supplier across a partner's hardware roadmap, transforming its revenue trajectory and investor perception.
Additional catalysts include the outcome of the Qarakal Quantum joint development agreement, which tests QTEX's architecture at milli-Kelvin temperatures in a working quantum environment; new defense and aerospace orders flowing through the U.S. subsidiary; and the potential monetization of the legacy medical business, which includes the FDA-cleared INSPIRA ART100 life-support system and the HYLA blood-monitoring platform. On the analyst front, coverage remains limited but constructive: the widely cited consensus reflects a Buy rating from a single analyst (Aegis Capital) with a $5.00 price target. Any expansion of sell-side coverage, upgrades, or target revisions could meaningfully influence sentiment, given how thinly the stock is followed.
QTEX's trajectory is closely tied to public and private investment in quantum computing infrastructure. The 2026 U.S. commitment of roughly $2 billion to the sector is a direct macro tailwind, reinforcing demand for the cryogenic hardware that underpins qubit scaling. Defense and aerospace budgets provide a second, less cyclical demand channel for the company's AME platform.
At the same time, the company operates in an early-stage market where revenue recognition, customer adoption, and manufacturing scale remain unproven. Higher interest rates and tighter capital markets historically weigh on pre-profitability, high-beta technology names; QTEX's elevated beta (a measure of volatility relative to the broader market) makes it especially sensitive to shifts in risk appetite. Geopolitically, the company's Israeli domicile and U.S. expansion strategy mean it must navigate export controls, national-security procurement rules, and cross-border technology-transfer considerations that could shape its addressable market.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality for timely monitoring. For investors tracking an early-stage, catalyst-driven name like QTEX, such tools can offer a structured way to monitor momentum and trend shifts. Explore the Trend Prediction Engine to see how these signals may apply to your watchlist.
Looking toward 2026 and beyond, the central question is whether QTEX can convert early technical validation into durable, recurring revenue. The long-term case rests on quantum computing's progression toward fault-tolerant, higher-qubit systems, which would structurally expand demand for advanced cryogenic interconnect. Success in securing a foundational supplier role with a leading hardware developer would be a strategic inflection point, while defense and aerospace adoption could provide nearer-term revenue and credibility.
Cost structure and margin sustainability remain open questions. The company is investing heavily in R&D and reported a trailing-twelve-month net loss alongside modest revenue, and the $10 million private placement completed in May 2026 signals continued reliance on external capital. Investors should monitor whether AME system sales, consumables, and services can scale into a margin-accretive model. Competitive threats from larger interconnect incumbents and the uncertain pace of quantum commercialization are the principal structural risks. Consensus expectations are limited to a single covering analyst, which amplifies both the upside implied by the $5.00 price target and the volatility of sentiment around the name.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Industry ComputerProcessingHardware
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LDRH | 24.05 | 0.04 | +0.15% |
| iShares iBonds 1-5 Year High Yield and Income Ladder ETF | |||
| INRO | 36.86 | 0.05 | +0.13% |
| iShares U.S. Industry Rotation Active ETF (INRO) | |||
| SUSL | 136.40 | 0.12 | +0.08% |
| iShares ESG MSCI USA Leaders ETF (SUSL) | |||
| HECO | 63.29 | -0.52 | -0.81% |
| State Street Galaxy Hedged Digital Asset Ecosystem ETF (HECO) | |||
| GSKH | 67.37 | -1.21 | -1.77% |
| GSK PLC ADRHEDGED | |||
A.I.dvisor tells us that QTEX and SSYS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QTEX and SSYS's prices will move in lockstep.
| Ticker / NAME | Correlation To QTEX | 1D Price Change % | ||
|---|---|---|---|---|
| QTEX | 100% | +15.04% | ||
| SSYS - QTEX | 31% Poorly correlated | +2.65% | ||
| CRSR - QTEX | 31% Poorly correlated | +2.59% | ||
| MBAI - QTEX | 29% Poorly correlated | -11.86% | ||
| AGMH - QTEX | 29% Poorly correlated | -4.19% | ||
| UMAC - QTEX | 26% Poorly correlated | -11.03% | ||
More | ||||
| Ticker / NAME | Correlation To QTEX | 1D Price Change % |
|---|---|---|
| QTEX | 100% | +15.04% |
| Computer Processing Hardware industry (39 stocks) | 15% Poorly correlated | +2.22% |
QTEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 41 of 45 cases where QTEX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QTEX's RSI Oscillator exited the oversold zone, 35 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 66 cases where QTEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +15.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTEX advanced for three days, in 142 of 173 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QTEX as a result. In 82 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QTEX turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 37 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for QTEX moved below the 200-day moving average on September 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QTEX entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.297) is normal, around the industry mean (7.321). P/E Ratio (0.000) is within average values for comparable stocks, (51.117). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (84.034) is also within normal values, averaging (51.774).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. QTEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.